Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchbpc-157tb-500gray marketadverse events

UCLA student reports panic attacks after BPC-157 and TB-500 self-injection

The anonymous biochemistry student says he started the stack for a hip flexor injury and did not consult a clinician before dosing.

PR
By Priya Raman · Science Reporter
Oct 16 18:33 ETSource: Daily Bruin

The wire

  1. 01A UCLA student told the Daily Bruin he injected a BPC-157 and TB-500 stack for an unresolved hip flexor injury, titrating up and then experiencing hour-long anxiety attacks several times a week.
  2. 02Self-reported adverse experiences with gray-market recovery peptides are the kind of presentation clinicians and telehealth operators are increasingly fielding as synthetic peptides await possible compounding access.
  3. 03This is a single anonymous anecdote with no clinical workup, no product testing and an implausibly reported dose; the article cites experts' concern about minimal long-term research.

From the source

Gym rat or lab rat? A UCLA student’s gamble with peptides

Needle pierces flesh, and the Wolverine stack is in.

Read at dailybruin.com
PeptiPrescribed peptides from $99/moSee all →